PATENT CLAIM ANALYSIS

Application Number: 15969222
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "340000"]

Abstract:
The present invention relates to novel 5-(carboxamide)-1-pyridinyl-1,2,4-triazole derivatives, to processes for the preparation of such compounds, to pharmaceutical compositions containing such compounds, and to the use of such compounds or compositions for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of renal and cardiovascular diseases.

Claim (Index 6):
Pharmaceutical composition of  claim 4  comprising one or more first active ingredients, which are compounds of general formula (I), and one or more further active ingredients, which are one or more additional therapeutic agents selected from the group consisting of diuretics, angiotensin AII antagonists, ACE inhibitors, beta-receptor blockers, mineralocorticoid receptor antagonists, antidiabetics, organic nitrates and NO donors, activators and stimulators of the soluble guanylate cyclase (sGC), antiinflammatory agents, immunosuppressive agents, phosphate binders, and/or compounds that modulate vitamin D metabolism.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 93.0
- Lexical Diversity: 1.68571
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15581064', '16098255', '14930157', '13819885', '16098202']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7705785980449327
- 35 USC 102 Novelty (BERT): 0.5577146414626953
- Combined Prediction Score: 0.749292202386709
- Mean Citation Score: 387.50195
- Max Citation Score: 439.27527
- Similarity Product: 304.98798030853453

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test